Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Convalescent Plasma vs Human Immunoglobulin for the Treatment of COVID-19 Pneumonia: A Randomized Controlled Trial
Conditions
Interventions
Plasma from COVID-19 convalescent patient
Human immunoglobulin
Locations
1
Mexico
Centenario Hospital Miguel Hidalgo
Aguascalientes, Mexico
Start Date
May 6, 2020
Primary Completion Date
November 26, 2020
Completion Date
November 26, 2020
Last Updated
November 30, 2020
NCT06927622
NCT05531032
NCT04466098
NCT04930874
NCT05077917
NCT04821934
Lead Sponsor
Centenario Hospital Miguel Hidalgo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions